The possible significance of egg yolk and yolk powder lutein and zeaxanthin content in the prevention of age related macular degeneration

被引:0
|
作者
Kerti Annamaria [1 ]
Pajor Ferenc [2 ]
Poti Peter [2 ]
Bardos Laszlo [1 ]
机构
[1] SZIE MKK, Allatelettani & Allat Egeszsegtani Tanszek, H-2103 Godollo, Hungary
[2] SZIE MKK, Allattenyesztes Tudomanyi Intezet, H-2103 Godollo, Hungary
关键词
ALPHA-CAROTENE; BETA-CAROTENE; VITAMIN-E; BIOAVAILABILITY; VEGETABLES; ESTERS; PLASMA; FRUITS; SERUM; RISK;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Age-related macular degeneration (AMD) is the leading cause of severe and irreversible vision loss in the world. As there is no effective treatment for all types of AMD, the prevention is of great importance. Oxycarotenoids have been shown to be good filters of harmful blue light, and their antioxidative properties have been demonstrated in vitro. The egg yolk contains considerable amount of these oxycarotenoids. The yolk powder as the processed egg products can be useful functional nutritive additive for the prevention of AMD in humans. The appropriate feeding of layers can result high concentration in yolk. These eggs and/or yolk powder are possible sources of the important oxycarotenoids. The HPLC determination of lutein and zeaxanthin and other antioxidant vitamins (retinol and tocopherol) from raw egg yolk and powder is presented in the study. The authors stated that egg yolk powder can be easily portioned and a good source of lutein and zeaxanthin for the AMD prevention.
引用
下载
收藏
页码:628 / 634
页数:7
相关论文
共 50 条
  • [11] Lutein and antioxidants in the prevention of age-related macular degeneration
    Rehak, M.
    Fric, E.
    Wiedemann, P.
    OPHTHALMOLOGE, 2008, 105 (01): : 37 - +
  • [12] Lutein and zeaxanthin and age-related macular degeneration in the Melbourne Visual Impairment Project
    Vu, HTV
    Robman, L
    Hodge, A
    McCarty, C
    Taylor, HR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [13] Lutein and Zeaxanthin Supplementation and Association With Visual Function in Age-Related Macular Degeneration
    Liu, Rong
    Wang, Tian
    Zhang, Bao
    Qin, Li
    Wu, Changrui
    Li, Qingshan
    Ma, Le
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (01) : 252 - 258
  • [14] Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration
    Cho, Eunyoung
    Hankinson, Susan E.
    Rosner, Bernard
    Willett, Walter C.
    Colditz, Graham A.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 87 (06): : 1837 - 1843
  • [15] Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration
    Loane, Edward
    Nolan, John M.
    O'Donovan, Orla
    Bhosale, Prakash
    Bernstein, Paul S.
    Beatty, Stephen
    SURVEY OF OPHTHALMOLOGY, 2008, 53 (01) : 68 - 81
  • [16] Evidence for Including Lutein and Zeaxanthin in Oral Supplements for Age-Related Macular Degeneration
    Musch, David C.
    JAMA OPHTHALMOLOGY, 2014, 132 (02) : 139 - 141
  • [17] Lutein and Zeaxanthin and Their Roles in Age-Related Macular Degeneration-Neurodegenerative Disease
    Mrowicka, Malgorzata
    Mrowicki, Jerzy
    Kucharska, Ewa
    Majsterek, Ireneusz
    NUTRIENTS, 2022, 14 (04)
  • [18] Preferential deficiency of meso-zeaxanthin and lutein relative to zeaxanthin in the macular pigment of subjects with age-related macular degeneration
    Landrum, JT
    Bone, RA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U277 - U277
  • [19] Lutein and zeaxanthin for the prevention and treatment of age-related macular degeneration (AMD): a systematic review and meta-analysis
    Vishwanathan, Rohini
    Berger, Samantha
    Johnson, Elizabeth J.
    FASEB JOURNAL, 2013, 27
  • [20] Lutein and Zeaxanthin against age related Macular Degeneration? Results from the Human Intervention Studies
    Arnold, Christin
    Boehm, Volker
    DEUTSCHE LEBENSMITTEL-RUNDSCHAU, 2016, 112 (04) : 165 - 167